Puma Biotech (PBYI) Tops Q1 EPS by 17c

Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.09, $0.17 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $51 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• C.H. Robinson acquires DeSpir Logistics for $75 million